致病性Bhlhe40+ GM-CSF+ CD4+ T细胞促进GVHD期间胃肠道间接同种抗原呈递
本研究探讨了急性移植物抗宿主病(GVHD)中胃肠道损伤的机制,发现Bhlhe40是调控CD4+ T细胞产生GM-CSF的关键转录调节因子,且GM-CSF介导胃肠道病理损伤。GM-CSF不受IL-6或IL-23调控,构成非冗余炎症通路,并通过增强供者来源树突状细胞活化促进间接同种抗原呈递,从而加剧结肠炎症。
要点
- Bhlhe40是调控CD4+ T细胞产生GM-CSF的关键转录因子。
- GM-CSF介导GVHD胃肠道病理损伤,且不受IL-6或IL-23调控。
- GM-CSF增强供者树突状细胞活化,促进间接同种抗原呈递。
核心结论
- Bhlhe40+ GM-CSF+ CD4+ T细胞是促结肠炎的T细胞群体,促进间接同种抗原呈递和胃肠道病理损伤。
- GM-CSF是结肠GVHD的关键调节因子和潜在治疗靶点。
研究设计与样本
- 研究采用GVHD动物模型,鉴定Bhlhe40为调控CD4+ T细胞产生GM-CSF的关键转录调节因子。
主要发现
- Bhlhe40调控CD4+ T细胞产生GM-CSF并介导GVHD胃肠道病理损伤。
- GM-CSF不受IL-6或IL-23调控,构成非冗余炎症通路。
- GM-CSF不影响调节性T细胞重建,但增强供者来源树突状细胞在结肠的活化及在mLNs的积聚。
- GM-CSF促进间接同种抗原呈递,导致结肠中促炎细胞因子表型的供者T细胞积聚。
临床怎么用
- GM-CSF可作为减轻结肠GVHD的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gastrointestinal (GI) tract involvement is the major cause of morbidity and mortality in acute graft-versus-host disease (GVHD), and pathological damage is largely attributable to inflammatory cytokine production. Recently, granulocyte-macrophage colony stimulating factor (GM-CSF) has been identified as a cytokine that mediates inflammation in the GI tract, but the transcriptional program that governs GM-CSF production and the mechanism by which GM-CSF links adaptive to innate immunity within this tissue site have not been defined. In the current study, we identified Bhlhe40 as a key transcriptional regulator that governs GM-CSF production by CD4+ T cells and mediates pathological damage in the GI tract during GVHD. In addition, we observed that GM-CSF was not regulated by either interleukin 6 (IL-6) or IL-23, which are both potent inducers of GVHD-induced colonic pathology, indicating that GM-CSF constitutes a nonredundant inflammatory pathway in the GI tract. Mechanistically, GM-CSF had no adverse effect on regulatory T-cell reconstitution, but linked adaptive to innate immunity by enhancing the activation of donor-derived dendritic cells in the colon and subsequent accumulation of these cells in the mLNs. In addition, GM-CSF promoted indirect alloantigen presentation, resulting in the accumulation of donor-derived T cells with a proinflammatory cytokine phenotype in the colon. Thus, Bhlhe40+ GM-CSF+ CD4+ T cells constitute a colitogenic T-cell population that promotes indirect alloantigen presentation and pathological damage within the GI tract, positioning GM-CSF as a key regulator of GVHD in the colon and a potential therapeutic target for amelioration of this disease.
引用
- Piper C, Zhou V, Komorowski R, et al. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD. Blood. 2020. PMID: 31880771. doi:10.1182/blood.2019001696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。